Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.080
-0.020 (-1.82%)
At close: Aug 21, 2026, 4:00 PM EDT
1.050
-0.030 (-2.78%)
After-hours: Aug 21, 2026, 7:59 PM EDT
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $2.46 million as of August 21, 2026. Its market cap has decreased by -95.62% in one year.
Market Cap
2.46M
Enterprise Value
2.59M
1-Year Change
-95.62%
Ranking
Category
Stock Price
$1.08
ChartMarket Cap Chart
Since February 10, 2023, Propanc Biopharma's market cap has increased from $571.43K to $2.46M, an increase of 330.61%. That is a compound annual growth rate of 51.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 2.46M | -65.69% |
| Dec 31, 2025 | 7.17M | 4,231.28% |
| Dec 31, 2024 | 165.57K | -48.84% |
| Dec 29, 2023 | 323.62K | -43.37% |
| Feb 10, 2023 | 571.43K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curis | 3.08M |
| 60 Degrees Pharmaceuticals | 3.00M |
| Matinas BioPharma Holdings | 2.92M |
| Valion Bio | 2.72M |
| Clearmind Medicine | 2.58M |
| Onconetix | 2.57M |
| Virax Biolabs Group | 2.54M |
| Oragenics | 2.37M |